• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/33

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

33 Cards in this Set

  • Front
  • Back
Goals of epidemiology; what do they all require?
describing disease in population, understanding underlying causes of disease, preventing disease

all require reliable & valid measurement
Central tenet of measurement theory
all scores equal the 'true' score plus measurement error
About reliability
higher measurement error => lower reliability
consequences of low reliability:
1) tendency to mask significance (i.e. biases studies towards finding no differences)
2) as a result, need larger sample size for sufficient statistical power
two measures of reliability
inter-observer agreement and test-retest reliability
What's Cohen's Kappa? What is it for?
Cohen's kappa is a measure of inter-observer agreement; equivalent to:

extent to which two measures agree beyond chance / maximum possible improvement in agreement

(% agreement observed - % chance agreement expected) /
(100%-chance agreement expected)

% agreement observed = (agreed '+' + agreed '-') / (total responses) i.e. ( a + d / (a+b+c+d) )

% agreement by chance expected = '+' agreement expected + '-' agreement expected

'+' chance agreement expected = ('+' from person A / total responses from person A) * ('+' from person B / total responses from person B)
sensitivity
the proportion of 'true' cases which the measure identifies as 'positive'
specificity
the proportion of 'true' non-cases which the measure identifies as 'negative'
positive predictive value
the proportion of positive-identified cases that are, in fact, 'true' cases
negative predictive value
the proportion of negative-identified cases that are, in fact, 'true' non-cases
What do sensitivity, specificity, PPV and NPV have in common?
they all are measures of 'criterion validity' i.e. of validity against a gold standard
Outbreak, epidemic, pandemic
All 3 describe 'elevated' levels of disease; outbreak is most localized geographically (i.e. county/city level), epidemic is more widespread and pandemic is global
Epidemiologic Triad
Vector is in the center; Environment, Agent, and Host are at vertices
Attack rate & what influences it
(# of exposed and sick)/(total # of exposed)

Some influencing factors: herd immunity, incubation period, virulence
Sample, Population, Bias
Population: everyone for whom you want to draw a conclusion

sample: representative sub-group (i.e. as congruently comprised as possible) of population

bias: when sample isn't representative of population
prevalence, incidence, odds
prevalence: # of cases / sample size
incidence: # of NEW cases / sample size
odds: # cases / # non-cases
When comparing two adult groups, what is most important variable to adjust to reach sound conclusions? Why?
Age is most important variable to adjust, because of physiological differences between people over chronological time
Case-fatality rate, years of potential life lost, disability-adjusted life-years
case-fatality rate = (# of dead from disease) / (# of people with disease in sample)

YPLL = Σ(65 - age of death); speaks more to early deaths

Disability-adjusted life-year: 1 year of healthy life lost to either death or disability
Advantages of survival analysis
1) accounts for censoring
2) addresses *time* until an event occurs
Most Impt. thing to remember about survival analysis
'cumulative survival' is multiplicative but the denominator of each proportion changes as people are censored/die
Hazard Ratio
relative risk integrated over time; used in survival analysis
With respect to timing of measures, what are the three epidemiologic research designs?
prospective (i.e. cohort), retrospective (i.e. case control) and concurrent
Observational Study Vs. Experiment
Experiment involves researcher intervention (i.e. is treatment-based); observational study only collects data
Ecologic study
exposures unlinked to outcome case-by-case, usually uses incidentally collected data (i.e. city-wide, country-wide, company-wide etc)
Cohort study
samples on *risk factor* and follows forward for outcome; no need to oversample for rare risk factors because oversampling is inherent

well-suited for relative risk because relative risk describes chance of *developing* disorder
Case-control study
sampled on *outcome*, tracks back through survey or records to risk factor; can oversample for rare outcomes (but is hard to deal with mathematically)

well-suited for odds ratio because OR describes odds of *having been exposed* given that you are disordered
Relative risk
describes relative chance of developing disorder;

( incidence in exposed) / ( incidence in unexposed)

(a / (a+b) / c / (c+d) )
Odds ratio
describes odds of having been exposed to risk factor

(odds of past exposure among diseased) / (odds of past exposure among healthy)

(a/c) / (b/d)
Attributable risk; Population attributable risk
excess cases among exposed (i.e. risk BEYOND background risk);

AR = incidence in exposed - incidence in unexposed

PAR = AR * prevalence of risk factor in a population

answers the question "how much could the incidence of this disease in pop. be reduced if risk factor eliminated?"
Null hypothesis
in population, there is no association or group difference
Type I; Type II error
Type I error: rejecting true H0 (i.e. false conclusion of difference)
Type II error: accepting false H0 (i.e. false conclusion of no difference)
p-value
the probability of obtaining the test statistic in question *if H0 is true*
95% confidence interval
interpreted as '95% probability that true value lies within bounds' -- really means that in repeated sampling value would appear within this interval 95% of the time
determinants of statistical power
# Effect size
# Prevalence of outcome and exposure
# Significance level (p)
# Reliability of measures
# Number of covariates (measured confounds)